Neurotechnology & Digital Health

Where the Brain Meets
Intelligent Technology

Axonetic develops neurotechnology solutions that bridge human cognition and digital health—enabling people to live, work, and thrive at their highest potential.

Platform launching 2028 · In development with academic & clinical partners
25+
Years Executive Experience
2
Research Partners
3
Flagship Platforms
Human Potential

Technology That Thinks With You, Not For You

At Axonetic, we believe the most powerful interface is the human mind itself. We develop neurotechnology and health platforms grounded in rigorous research, designed to augment cognitive performance, support clinical decision-making, and transform the way organisations understand wellbeing.


Our work is rooted in academic excellence and executive insight—combining cutting-edge neuroscience with proven business strategy to deliver solutions that are not just innovative, but deployable.

Platforms Built for the Frontier of Health

From enterprise wellness to clinical-grade neurotech, our product suite is designed for organisations that take human performance seriously.

Cognitive Performance Monitoring

Real-time neurometric dashboards that track executive cognitive load, decision fatigue, and attention states—enabling organisations to optimise performance at scale.

Digital Health Integration

Seamless API-driven integration with clinical health systems, wearables, and EHR platforms, enabling continuous, passive health monitoring for enterprise and clinical environments.

Neurofeedback Therapeutics

Evidence-based neurofeedback protocols for stress, anxiety, and cognitive rehabilitation, developed in partnership with leading university research groups.

Executive Wellbeing Analytics

A strategic intelligence layer for CHROs and boards: aggregate wellbeing signals, burnout risk models, and leadership resilience reports—confidential, GDPR-compliant, and actionable.

Clinical Decision Support

AI-assisted neurodiagnostic tools for clinicians, synthesising multimodal biosignals into structured clinical insights to support faster, more accurate treatment pathways.

Research & Advisory

Bespoke neurotechnology strategy consulting for healthcare systems, corporates, and investment groups—drawing on 25+ years of executive experience and active academic research.

From Research to Real-World Impact

Phase 01 · Q1 2026 – Q3 2026
Foundation & Partnerships

Established research partnerships with Universidad Pontificia Comillas and Turicum Innovation. Core IP development and clinical protocol design underway.

Phase 02 · Q1–Q2 2027
Platform Alpha & Pilot Deployments

Private alpha launch with selected enterprise clients. Cognitive monitoring and wellbeing analytics pilots initiated with partner organisations.

Phase 03 · 2028
Clinical Validation Studies

Academic-grade clinical trials in partnership with university medical centres. Publication of neurofeedback efficacy data.

Phase 04 · 2029
Market Launch & Scale

Full commercial launch across European markets. Series A fundraising, regulatory CE marking for medical device modules.

Axonetic — human connection at the heart of neurotechnology
Technology designed around people

Built on Academic & Innovation Excellence

We develop our science in collaboration with world-class institutions, ensuring every product is grounded in peer-reviewed research and clinical rigour.

Universidad Pontificia Comillas
Universidad Pontificia Comillas
Turicum Innovation
Turicum Innovation

Interested in a research or commercial partnership? Get in touch →

Be First to Experience Axonetic

Join our waitlist for early platform access, research updates, and priority onboarding when we launch.

No spam. Unsubscribe at any time. GDPR compliant.